Most Organizations Engaged with ProVation MD After Olympus Selected it as a Preferred Replacement
The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, signed agreements in 2015 to replace Olympus ® EndoWorks ® with ProVation ® MD at 86 healthcare facilities – decisions influenced heavily by Olympus selecting ProVation MD as a preferred replacement for its endowriter software, which is being retired in 2018. Recognizing the opportunity presented by the Olympus announcement to standardize procedure documentation system-wide, several integrated delivery networks will also implement the industry-leading gastroenterology structured reporting software across GI suites in an additional 27 facilities.
Among the health systems making the move from EndoWorks to ProVation MD is Florida Medical Clinic, a multi-specialty clinic providing residents in two Florida counties with access to the latest advances in patient care. Founded in 1993, Florida Medical Clinic is made up of 20 locations staffed by a dedicated team of more than 200 providers comprised of primary care and academically trained specialists in more than 40 medical and surgical modalities.
“After thoroughly evaluating replacement options, the ‘preferred replacement vendor’ stamp of approval by Olympus coupled with the promise of an easy transition without extra costs for dedicated servers and migration support moved ProVation MD to the top of our list,” said Sandy Harris, Director of Florida Medical Center ASC. “Its clinician-friendly design, minimal impact on productivity and secure interfacing with our EHR system, as well as its outstanding reputation as an industry leader in GI documentation, reporting and coding, ultimately garnered unanimous physician approval and sealed the deal.”
The only dedicated structured reporting and coding solution that provides clinically relevant, intuitive software for more accurate and complete documentation of procedures, ProVation MD Gastroenterology allows physicians to efficiently capture robust detail from even the most complex procedures. It then automatically generates clear, complete procedure notes and appropriate reimbursement codes, quickly, easily and without dictation. By automatically applying the reimbursement codes and disseminating critical procedural information, ProVation MD ensures appropriate payment, reduces costs and streamlines quality reporting while improving clinical communication and care coordination.
To lessen the impact on its customers as it phases out EndoWorks over three years, Olympus identified ProVation MD and one other software solution as recommended replacements. That means Wolters Kluwer is one of just two vendors able to license an Olympus-developed export utility to seamlessly migrate data from EndoWorks to ProVation MD.
“This is an important distinction, as the utility enables a more robust and comprehensive transition that is transparent to end users and requires limited assistance from the customer's IT staff,” said David A. Del Toro, President & CEO of Clinical Software Solutions at Wolters Kluwer. “That export utility, combined with our 20 years as a leader in GI documentation and extensive experience in managing clinical data, are why a growing number of EndoWorks customers are turning to ProVation for a smooth, disruption-free migration. Also at play is our unparalleled end user training and world-class customer service, which combine to ensure maximum clinician adoption and accelerated ROI.”
Click here for more information on converting to ProVation MD from Olympus EndoWorks.
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.